|Market Size in 2022||Market Forecast in 2030||CAGR (in %)||Base Year|
|USD 42.04 billion||USD 69.73 billion||6.53%||2022|
Infusion Pharmacy Management Market
Pharmacy that provides prepared solutions for direct administration to a patient in a private residence, long term care facility, or hospice setting by means of irrigation, enteral, parenteral, intravenous, intramuscular, subcutaneous, or intraspinal infusion.The global infusion pharmacy management market size was worth around USD 42.04 billion in 2022 and is predicted to grow to around USD 69.73 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.53% between 2023 and 2030.
The report analyzes the global infusion pharmacy management market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the infusion pharmacy management industry.
Drugs or medications are administered during infusion treatment using a sterilized catheter or needle. A qualified healthcare provider regularly inserts them and secures them in the patient's vein. Only patients who do not react to oral treatment and whose health has not yet improved are often recommended this therapy. Pain management medications, antibiotics, antiviral, antifungal, and nutritional pharmaceuticals are infused into the patient's body at the infusion pharmacy via a needle or catheter. The infusion medicine system is used to treat a variety of diseases, including cancer, gastrointestinal disorders, diabetes, and diseases related to pain.
The growing trend of homecare services drives the market growth
As the most costly option for infusion, hospital-based clinics have drawbacks related to expense and patient discomfort. If a clinic only operates within certain hours, there may be more inconvenience because patients would have to wait longer for appointments. On the other hand, given their dispersed location across the community and lower cost, freestanding infusion clinics may be a little more practical than hospital-based clinics. If these alternate sites are not connected to the patient's primary oncology team, there may be fragmentation of care as a consequence of poor communication between the various care teams. Even if the price is nearly the same as that of freestanding infusion clinics, the cost of home infusion is far less expensive than that of hospital-based clinics. This method is better for standalone infusion clinics, which need transportation concerns because it makes it simple to receive infusions at home. Thus, this is expected to drive the growth of the global infusion pharmacy management market during the forecast period.
The high cost and dearth of skilled professional is expected to hamper the market
Some of the issues that must be addressed for future development are the cost of an infusion pharmacy system and the lack of qualified individuals to run one. There are several infusion pharmacy management strategies for antibiotics, antimicrobials, pain relief, enteral feeding, and other medications. Pain treatment infusion pharmacy is the most popular type of this type of management. Home care infusion pharmacy administration is more expensive than hospital infusion pharmacy management because it requires more experienced nursing facilities. Many governments are taking the initiative to extend coverage for infusion pharmacy management to both public and private insurance plans. Thus, the high cost and dearth of skilled professionals are expected to hamper the infusion pharmacy management industry growth over the forecast period.
Increasing incidence of chronic disease globally offers a lucrative opportunity
The increasing incidence of chronic disease globally is expected to provide a lucrative opportunity for infusion pharmacy management market growth over the forecast period. Chronic disease includes various diseases including cardiovascular, cancer, diabetes, and others. For instance, as per CDC, an estimated 537 million individuals (20-79 years old) will have diabetes in 2021. By 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. In addition, globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018, according to estimates from the International Agency for Research on Cancer (IARC). Simply because of population expansion and age, it is anticipated that by 2040 there would be 16.3 million cancer deaths and 27.5 million new cancer cases worldwide. Thus, the aforementioned fact supports the market growth during the forecast period.
Strict regulatory requirements pose a major challenge to the market growth
The category that a certain device belongs to determines the level of regulatory scrutiny, which differs from one location to another. Several state boards of pharmacy rules apply to the use of pharmacy automation systems in medical settings. These boards are state agencies in charge of monitoring and policing pharmacy operations as well as granting pharmacists state licenses. As a result, manufacturers of automated pharmacy systems are required to adhere to a variety of regulations; doing so takes time and might delay the introduction of new products.
The global infusion pharmacy management industry is segmented based on product type, application, and region.
Based on the product type, the global market is bifurcated into antibiotics, antimicrobials, pain management, enternal nutrition, and others. The pain management segment is expected to capture the largest market share over the forecast period. This is because a variety of pain syndromes, including fibromyalgia, neuropathic pain, phantom limb pain, post-herpetic neuralgia, complex regional pain syndromes, diabetic neuropathy, and central pain related to stroke or spinal cord, can be treated with pain management. On the other hand, the antibiotics segment is expected to grow at the highest CAGR during the forecast period. Antibiotics are drugs used to treat infections caused by bacteria in both people and animals. They do this by either killing the germs or by making it harder for them to develop and reproduce. Thus, the growing prevalence of various infectious diseases is expected to drive segment growth during the forecast period.
Based on the application, the global infusion pharmacy management industry is bifurcated into hospitals & clinics, ambulatory surgical centers, and homecare. The hospital & clinic segment is expected to dominate the market over the forecast period. The segment growth is attributed to the growing sizeable population of patients with various diseases. On the other hand, the homecare segment is expected to grow at the highest CAGR over the forecast period. The segment growth is owing to the benefits of home infusion therapy. This service allows patients an accessible treatment opportunity in the environment they are most comfortable and relaxed.
|Report Attributes||Report Details|
|Report Name||Infusion Pharmacy Management Market Research Report|
|Market Size in 2022||USD 42.04 Billion|
|Market Forecast in 2030||USD 69.73 Billion|
|Growth Rate||CAGR of 6.53%|
|Number of Pages||214|
|Key Companies Covered||MCKESSON CORPORATION, CARECENTA, INC., Brightree, SSRx, Providence, ContinuumRx, PharMerica Corporation, CarepathRx, Inovalon, Centene Corporation, Prochant, LLC, OSF Healthcare System, Sentara Healthcare, CVS Health, Norton Healthcare, Cigna, Magellan Rx Management, LLC, Soleo Health, Cleveland Clinic, EVERSANA, Cardinal Health, InfuCare Rx, Inc., Paragon Healthcare and Prime Therapeutics LLC among others.|
|Segments Covered||By Product Type, By Application, and By Region|
|Regions Covered||North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)|
|Historical Year||2017 to 2021|
|Forecast Year||2023 - 2030|
|Customization Scope||Avail customized purchase options to meet your exact research needs. Request For Customization|
North America is expected to dominate the market during the forecast period
North America is expected to dominate the infusion pharmacy management market over the forecast period. The growth in the region is attributed to the growing prevalence of chronic disease coupled with rising geriatric population. For instance, according to the Centers for Disease Control and Prevention, in the United States, 1,752,735 new cases of cancer were recorded in 2019, while 599,589 people passed away from the disease. 439 new instances of cancer and 146 cancer-related deaths were recorded for every 100,000 persons.
In addition, as per the same source, in 2019, 1.0% of adults aged 18 to 44, 3.6% of adults aged 45 to 54, 9.0% of adults aged 55 to 64, 14.3% of adults aged 65 to 74, and 24.2% of people aged 75 and older reported having heart disease. Furthermore, according to the 2021 American Community Survey, 16.8% of the country's population, or 55,892,014 individuals, was 65 years of age or older. Thus, the growing incidence of chronic disease along with the increasing elderly population is expected to rise in demand for the infusion pharmacy management industry over the forecast period.
The Asia-Pacific market is expected to rise significantly over the projected period as a result of the rising prevalence of chronic diseases and the expanding usage of cutting-edge healthcare facilities in emerging countries like China and India. Additionally, it is projected that the presence of a sizeable patient population and the growing public awareness of the benefits of infusion treatment will drive market revenue growth in this market. Additionally, it is projected that the availability of low-cost infusion pumps and the increasing frequency of alliances and collaborations between significant corporations would support market revenue development.
The global infusion pharmacy management market is dominated by players like:
By Product Type
The increasing prevalence of chronic diseases such as Cancer, gastrointestinal disorder, diabetes, and pain-related diseases, and others are driving the global Infusion Pharmacy Management Market.
MCKESSON CORPORATION, CARECENTA, INC., Brightree, SSRx, Providence, ContinuumRx, PharMerica Corporation, CarepathRx, Inovalon, Centene Corporation, Prochant, LLC, OSF Healthcare System, Sentara Healthcare, CVS Health, Norton Healthcare, Cigna, Magellan Rx Management, LLC, Soleo Health, Cleveland Clinic, EVERSANA, Cardinal Health, InfuCare Rx, Inc., Paragon Healthcare and Prime Therapeutics LLC among others.
The Global Infusion Pharmacy Management Market is Segmented on the basis of Service, End-User, and Geography.